These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 26316393

  • 1. Circulating Interferon-Inducible Protein IFI16 Correlates With Clinical and Serological Features in Rheumatoid Arthritis.
    Alunno A, Caneparo V, Bistoni O, Caterbi S, Terenzi R, Gariglio M, Bartoloni E, Manzo A, Landolfo S, Gerli R.
    Arthritis Care Res (Hoboken); 2016 Apr; 68(4):440-5. PubMed ID: 26316393
    [Abstract] [Full Text] [Related]

  • 2. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis.
    Sun X, Zhao J, Liu R, Jia R, Sun L, Li X, Li Z.
    Scand J Rheumatol; 2013 Apr; 42(2):97-101. PubMed ID: 23311967
    [Abstract] [Full Text] [Related]

  • 3. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D, Anouk M, Golan I, Paran D, Kaufman I, Wigler I, Levartovsky D, Litinsky I, Elkayam O.
    Arthritis Rheum; 2006 Feb 15; 55(1):53-6. PubMed ID: 16463412
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T, Shimada K, Ozawa N, Hayakawa H, Hagiwara F, Nakayama H, Sugii S, Ozawa Y, Tohma S.
    J Rheumatol; 2006 Dec 15; 33(12):2390-7. PubMed ID: 16924694
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anti-cyclic citrullinated peptide antibodies in patients with sarcoidosis.
    Kobak S, Ylmaz H, Sever F, Duran A, Sen N.
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Oct 20; 31(3):206-10. PubMed ID: 25363220
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
    Zeng X, Ai M, Tian X, Gan X, Shi Y, Song Q, Tang F.
    J Rheumatol; 2003 Jul 20; 30(7):1451-5. PubMed ID: 12858440
    [Abstract] [Full Text] [Related]

  • 11. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
    Mondini M, Vidali M, De Andrea M, Azzimonti B, Airò P, D'Ambrosio R, Riboldi P, Meroni PL, Albano E, Shoenfeld Y, Gariglio M, Landolfo S.
    Arthritis Rheum; 2006 Dec 20; 54(12):3939-44. PubMed ID: 17133607
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis.
    Gonzalez SM, Payne JB, Yu F, Thiele GM, Erickson AR, Johnson PG, Schmid MJ, Cannon GW, Kerr GS, Reimold AM, Sokolove J, Robinson WH, Mikuls TR.
    J Periodontol; 2015 Feb 20; 86(2):222-31. PubMed ID: 25299390
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
    Maraina CH, Nurdayana AK, Rusni D, Azwany Y.
    Int J Rheum Dis; 2010 Oct 20; 13(4):335-9. PubMed ID: 21199468
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Autoantibodies in prediction of the development of rheumatoid arthritis among healthy relatives of patients with the disease.
    Ramos-Remus C, Castillo-Ortiz JD, Aguilar-Lozano L, Padilla-Ibarra J, Sandoval-Castro C, Vargas-Serafin CO, de la Mora-Molina H, Ramos-Gomez A, Sanchez-Ortiz A, Avila-Armengol H, Aceves-Avila FJ.
    Arthritis Rheumatol; 2015 Nov 20; 67(11):2837-44. PubMed ID: 26245885
    [Abstract] [Full Text] [Related]

  • 18. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A, Plischke H, Kellner H, Gruber R.
    Ann N Y Acad Sci; 2005 Jun 20; 1050():295-303. PubMed ID: 16014545
    [Abstract] [Full Text] [Related]

  • 19. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis.
    Candia L, Marquez J, Gonzalez C, Santos AM, Londoño J, Valle R, Zabaleta J, Yaqub Z, Espinoza LR.
    J Clin Rheumatol; 2006 Oct 20; 12(5):226-9. PubMed ID: 17023808
    [Abstract] [Full Text] [Related]

  • 20. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis].
    Galati S, Beauvillain C, Renier G, Jeannin P, Masson C, Chevailler A.
    Ann Biol Clin (Paris); 2008 Oct 20; 66(2):157-64. PubMed ID: 18390426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.